These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 26855316

  • 1. C5a and pain development: An old molecule, a new target.
    Quadros AU, Cunha TM.
    Pharmacol Res; 2016 Oct; 112():58-67. PubMed ID: 26855316
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
    Liu Y, Xu SQ, Long WJ, Zhang XY, Lu HL.
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7994-8003. PubMed ID: 30536348
    [Abstract] [Full Text] [Related]

  • 6. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL, Chen J, Yang F, Li GQ, Zheng LX, Wu YZ.
    Hepatology; 2014 Jul; 60(1):114-24. PubMed ID: 24604562
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H, Wada Y, Kawano Y, Murakami Y, Irie A, Taniguchi K, Kikuchi K, Yamada G, Suzuki K, Honda J, Wilson-Morifuji M, Araki N, Eto M, Baba H, Imamura T.
    Clin Cancer Res; 2013 Apr 15; 19(8):2004-13. PubMed ID: 23287562
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury.
    Brandolini L, Grannonico M, Bianchini G, Colanardi A, Sebastiani P, Paladini A, Piroli A, Allegretti M, Varrassi G, Di Loreto S.
    Neurotox Res; 2019 Jul 15; 36(1):163-174. PubMed ID: 30953275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy.
    Li J, Liu B.
    Cytokine Growth Factor Rev; 2021 Apr 15; 58():75-81. PubMed ID: 33558131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat.
    Daveau M, Benard M, Scotte M, Schouft MT, Hiron M, Francois A, Salier JP, Fontaine M.
    J Immunol; 2004 Sep 01; 173(5):3418-24. PubMed ID: 15322206
    [Abstract] [Full Text] [Related]

  • 15. The harmful role of c5a on innate immunity in sepsis.
    Ward PA.
    J Innate Immun; 2010 Sep 01; 2(5):439-45. PubMed ID: 20588003
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional identification of the stable transfection C5aR cell line Molt-4.
    Zhang C, Xu R, Wang J, Han G, Chen G, Wang R, Wei H, Shen B, Ma Y, Li Y.
    Cell Mol Immunol; 2007 Dec 01; 4(6):461-5. PubMed ID: 18163958
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.